Posts

Showing posts from January, 2025

Ketogenic Diet: A Balanced Look?

  Ketogenic Diet: A Balanced Look? WHY YOU SHOULD DO KETO 1. Keto Diets Are Highly Anti-Inflammatory and May Inhibit Cancer Growth One of the most intriguing benefits of following a well-formulated ketogenic diet is its anti-inflammatory potential and possible anti-cancer effects. Chronic inflammation is linked to a wide range of diseases, including cancer, heart disease, and autoimmune conditions.  Emerging research suggests ketogenic diets may dampen inflammation through several mechanisms: Beta-hydroxybutyrate (BHB), one of the main ketone bodies produced during ketosis, blocks inflammatory pathways associated with disease states. Studies indicate BHB acts as a signaling molecule with epigenetic influence, inhibiting inflammatory genes and cytokines. Ketogenic diets have been shown to reduce reactive oxygen species that propagate free radical damage and inflammation. Lower blood sugar levels attained by carb restriction contribute to these antioxidant effects. The ketone bo...

Flubendazole and Other Microtubule Disrupters

  Flubendazole Flubendazole is an anthelmintic, used both in humans and for veterinarian purposes. It is very close chemically to mebendazole, the only difference being an added fluorine group.[2] Human use It is available for human use to treat worm infections. In certain countries such as France, it is inexpensive and available OTC (without prescription)[3] under the brand name Fluvermal as an alternative to mebendazole which is not currently sold there.[4] Under veterinary use, its brand name is Flutelmium which is a paste manufactured by Janssen Pharmaceutica N.V. used by veterinarians for protection against internal parasites and worms in dogs and cats. Other brand names are Flubenol, Biovermin, and Flumoxal.[5] The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma ( 2010 ) On-patent and off-patent drugs with previously unrecognized anticancer activity could be ra...